Escitalopram — Chemistry, Molecular Pharmacology & Pharmacogenomics Jane Doe, Michael Brown, Sarah Wilson Abstract Escitalopram, the S-enantiomer of racemic citalopram, is a widely used selective serotonin reuptake inhibitor (SSRI) approved for the treatment of major depressive disorder and generalized anxiety disorder. This review provides an in-depth look at escitalopram's molecular pharmacology, the significance of its…

Clinical Efficacy of Escitalopram Across Psychiatric and Somatic Disorders: 2019–2025 Umbrella Review Biao Wang, Keqing Li, Xiufeng Xu Abstract This umbrella review aggregates high-quality randomized controlled trials (RCTs) and meta-analyses published from 2019 to 2025, providing a definitive source for the clinical efficacy of escitalopram across psychiatric and somatic disorders. Escitalopram has demonstrated significant efficacy…

Therapeutic Evidence for Gabapentin in Humans & Animals Biao Wang, Keqing Li, Xiufeng Xu Abstract Gabapentin, a medication approved for the treatment of various conditions, including focal epilepsy, post-herpetic neuralgia (PHN), and neuropathic pain, has also found utility in psychiatric disorders, perioperative pain management, and veterinary applications. This umbrella systematic review aims to aggregate and…

Finding Your Dose: Lexapro 5 mg, 10 mg, 20 mg, 30 mg What Really Counts as ‘Low’ or ‘High’? Confused about Lexapro dosages? Learn about 5 mg, 10 mg, 20 mg, and 30 mg doses, what counts as low or high, and how to find your ideal dose for anxiety. Morning vs. Evening: Chrono Pharmacology…

Re-signalling the Blues: How Tadalafil Might Accelerate Antidepressant Response in Major Depressive Disorder Introduction: A New Angle on Antidepressant Acceleration Major depressive disorder (MDD) remains one of the most prevalent and disabling psychiatric conditions worldwide. Despite advances in pharmacotherapy, most first-line treatments, particularly selective serotonin reuptake inhibitors (SSRIs), require several weeks to take effect, and…

Antipsychotics Beyond Dopamine: The Muscarinic Turn Medically reviewed by Paul E. Bebbington, MA, MPhil, FRCPsych; Phern-Chern Tor, MBBS; and Pichet Udomratn, MD | Last updated: 12 June 2025 Introduction For more than half a century, antipsychotic treatment has rested on the pharmacological foundation of dopamine D2 antagonism: the idea that attenuating hyperdopaminergic signaling in striatal circuits would quell hallucinations,…

Safety, Adverse Events, Interactions & Abuse Potential of Gabapentin Zhen Wang1 ✉, Mei Li2 1Department of Pharmacology, Peking University, Beijing, China 2School of Pharmacy, Fudan University, Shanghai, China Abstract Gabapentin is widely prescribed for a range of conditions, including neuropathic pain, epilepsy, and anxiety disorders. While its therapeutic benefits are well-established, concerns regarding its safety, adverse effects, drug…

Abilify Side Effects: Comprehensive Review of Short- and Long-Term Risks Common Abilify Side Effects: Nausea, Insomnia, Restlessness The most frequently reported side effects of Abilify (aripiprazole) are generally mild to moderate in severity and often emerge within the first weeks of treatment. According to pooled data from FDA registration trials, the most common adverse drug…

Abilify Dosage Guide: Evidence-Based Oral and Long-Acting Regimens Approved Abilify Dosages by Indication (Schizophrenia, Bipolar I, MDD Augmentation, Autism Irritability, Tourette) Abilify (aripiprazole) is approved for multiple psychiatric indications, each with specific dosing recommendations based on clinical trial data and regulatory guidance. For adults with schizophrenia, the typical starting abilify dose is 10 mg or…

Abilify Withdrawal Symptoms and Timeline: An Evidence-Based Review Pathophysiology of Abilify Withdrawal Withdrawal from Abilify (aripiprazole) is primarily mediated by neuroadaptive changes in dopaminergic and serotonergic pathways. As a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, aripiprazole modulates neurotransmission in a unique manner compared to full antagonists. Upon abrupt discontinuation, the sudden loss…